TickerFacts.

Endonovo Therapeutics, Inc. (ENDV): Long-Term Debt

Annual figures by period end, from SEC filings.

Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$7.15M
As of 2022-12-31
+1.3%
3-year compound annual growth
-0.6%
5-year compound annual growth
$8.16M2014-12-31: $1.57M2015-12-31: $28.6K2016-12-31: $3.19M2017-12-31: $7.36M2018-12-31: $8.16M2019-12-31: $6.87M2020-12-31: $6.84M2021-12-31: $7.26M2022-12-31: $7.15M$7.15M
2014-12-31 Long-Term Debt (USD) 2022-12-31
Period endedLong-Term DebtChange YoYSource filing
2022-12-31$7.15M-1.4%2023-04-17, Balance as of period end
2021-12-31$7.26M+6.2%2022-04-14, Balance as of period end
2020-12-31$6.84M-0.6%2021-04-13, Balance as of period end
2019-12-31$6.87M-15.7%2020-05-04, Balance as of period end
2018-12-31$8.16M+10.9%2019-04-15, Balance as of period end
2017-12-31$7.36M+130.3%2018-04-06, Balance as of period end
2016-12-31$3.19Mn/m2017-04-17, Balance as of period end
2015-12-31$28.6K-98.2%2016-05-17, Balance as of period end
2014-12-31$1.57Mn/a2015-06-15, Balance as of period end